Drug safety and regulation

This publication has 9 references indexed in Scilit:

• The influence of big pharma
  BMJ, 2005
• COX-2 Inhibitors — A Lesson in Unexpected Problems
  New England Journal of Medicine, 2005
• Suicide, depression, and antidepressants
  BMJ, 2005
• Safety concerns at the FDA
  The Lancet, 2005
• Vioxx: lessons for Health Canada and the FDA
  CMAJ : Canadian Medical Association Journal, 2005
• Vioxx, the implosion of Merck, and aftershocks at the FDA
  The Lancet, 2004
• FDA is incapable of protecting US “against another Vioxx”
  BMJ, 2004
• Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
  BMJ, 2004
• A model for the future conduct of pharmacovigilance
  Pharmacoepidemiology and Drug Safety, 2002